Salvus Wealth Management’s Adobe ADBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,157
Closed -$405K 128
2025
Q4
$405K Buy
1,157
+72
+7% +$24.5K 0.23% 95
2025
Q3
$383K Sell
1,085
-426
-28% -$153K 0.21% 97
2025
Q2
$585K Buy
1,511
+276
+22% +$106K 0.34% 75
2025
Q1
$474K Buy
1,235
+22
+2% +$9.43K 0.3% 84
2024
Q4
$539K Buy
1,213
+32
+3% +$15.8K 0.34% 77
2024
Q3
$611K Buy
1,181
+322
+37% +$177K 0.38% 71
2024
Q2
$477K Buy
859
+41
+5% +$19.9K 0.33% 81
2024
Q1
$413K Sell
818
-359
-31% -$206K 0.28% 83
2023
Q4
$702K Buy
1,177
+7
+0.6% +$4.04K 0.5% 53
2023
Q3
$597K Buy
1,170
+16
+1% +$8.39K 0.47% 58
2023
Q2
$564K Sell
1,154
-217
-16% -$87.4K 0.43% 61
2023
Q1
$528K Buy
1,371
+137
+11% +$48.7K 0.43% 64
2022
Q4
$415K Sell
1,234
-148
-11% -$47.3K 0.38% 69
2022
Q3
$380K Buy
1,382
+32
+2% +$12.1K 0.36% 71
2022
Q2
$494K Buy
1,350
+250
+23% +$102K 0.44% 60
2022
Q1
$501K Buy
1,100
+171
+18% +$82.3K 0.38% 64
2021
Q4
$527K Buy
929
+113
+14% +$70.6K 0.39% 60
2021
Q3
$470K Buy
816
+141
+21% +$88.7K 0.38% 61
2021
Q2
$395K Buy
+675
New +$348K 0.33% 66

Other funds holding ADBE

Salvus Wealth Management's ADBE Position: Q1 2026 in Review

Salvus Wealth Management sold out of Adobe (ADBE) in Q1 2026, closing a stake of 1,157 shares — an estimated $405K sold.

Salvus Wealth Management first reported a position in ADBE in Q2 2021 and held it in 19 quarters. The position peaked at $702K in Q4 2023. 2,178 funds tracked by Wall St. Rank hold ADBE as of Q1 2026.

  • Salvus Wealth Management reported no remaining Adobe position as of Q1 2026 after selling out during the quarter.
  • Salvus Wealth Management sold 1,157 Adobe shares in Q1 2026, an estimated $405K.
  • Salvus Wealth Management first reported a position in Adobe in Q2 2021 and held it in 19 quarters.
  • Salvus Wealth Management's Adobe position peaked at $702K in Q4 2023.
  • 2,178 funds tracked by Wall St. Rank held Adobe as of Q1 2026.

Based on Salvus Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.